These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28847625)

  • 1. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
    Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
    Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1 and sporadic optic gliomas.
    Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
    Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
    Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P
    Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S; Flaherty M; Billson F; North K
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
    Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
    J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optic Pathway Gliomas in Neurofibromatosis Type 1.
    Campen CJ; Gutmann DH
    J Child Neurol; 2018 Jan; 33(1):73-81. PubMed ID: 29246098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic Gliomas in Neurofibromatosis Type 1.
    Parkhurst E; Abboy S
    J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history and clinical management of optic pathway glioma.
    Astrup J
    Br J Neurosurg; 2003 Aug; 17(4):327-35. PubMed ID: 14579898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
    Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of surgery in optic pathway/hypothalamic gliomas in children.
    Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C
    J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas.
    Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F
    J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.
    Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK
    J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurofibromatosis type 1 and optic pathway gliomas. A series of 80 patients].
    Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; García-Segura JM; Botella MP
    Rev Neurol; 2008 May 1-15; 46(9):530-6. PubMed ID: 18446694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.
    Amato A; Imbimbo BP; Falsini B
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5636-5653. PubMed ID: 37401302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
    Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
    Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic pathway gliomas in adults.
    Shofty B; Constantini S; Bokstein F; Ram Z; Ben-Sira L; Freedman S; Vainer G; Kesler A
    Neurosurgery; 2014 Mar; 74(3):273-9; discussion 279-80. PubMed ID: 24335817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic pathway glioma and endocrine disorders in patients with and without NF1.
    Gil Margolis M; Yackobovitz-Gavan M; Toledano H; Tenenbaum A; Cohen R; Phillip M; Shalitin S
    Pediatr Res; 2023 Jan; 93(1):233-241. PubMed ID: 35538247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1.
    Sellmer L; Farschtschi S; Marangoni M; Heran MKS; Birch P; Wenzel R; Mautner VF; Friedman JM
    Orphanet J Rare Dis; 2018 Apr; 13(1):62. PubMed ID: 29685181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.